盐酸氨溴索联合布地奈德雾化吸入治疗支气管肺炎的疗效观察

Ambroxol Hydrochloride Combined with Budesonide Inhalation in the Treatment of Bronchial Pneumonia

目的探讨盐酸氨溴索联合布地奈德雾化吸入治疗支气管肺炎的临床疗效。方法选取2016年4月—2017年4月本院80例支气管肺炎患者,根据随机数字法,将其分为对照组(布地奈德雾化吸入)和观察组(盐酸氨溴索联合布地奈德雾化吸入),每组各40例,比较两组治疗的临床疗效、症状缓解时间、消失时间及住院时间。结果与对照组相比,观察组治疗的效率明显增高,差异有统计学意义(P<0.05);与对照组相比,观察组症状缓解时间、消失时间及住院时间均明显缩短,差异有统计学意义(P<0.05)。结论盐酸氨溴索联合布地奈德雾化吸入治疗能够明显改善支气管肺炎患者的临床症状,提高治疗的临床疗效,值得临床广泛推广。

Objective to investigate the clinical efficacy of ambroxol hydrochloride combined with budesonide inhalation in the treatment of bronchial pneumonia. Methods from April 2016 to April 2017 in our hospital 80 cases of bronchial pneumonia patients,according to randomly divided into control group(budesonide)and observation group(ambroxol hydrochloride combined with budesonide inhalation),40 cases in each group. The clinical efficacy,remission time and disappearance time the hospitalization time. Results compared with control group,the total effective rate in observation group was significantly higher,the difference was statistically significant(P<0.05);compared with the control group,the observation group symptoms time,disappeared time and hospitalization time were significantly reduced,the difference was statistically significant(P<0.05). Conclusion ambroxol combined with budesonide inhalation treatment can significantly improve the clinical symptoms of patients with bronchial pneumonia,improve the clinical efficacy of treatment,and is worthy of extensive clinical promotion.